Glenview Trust Co Takes $13.23 Million Position in Danaher Corporation $DHR

Glenview Trust Co bought a new position in shares of Danaher Corporation (NYSE:DHR) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 18,371 shares of the conglomerate’s stock, valued at approximately $13,228,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in DHR. BlackRock Inc. bought a new position in shares of Danaher in the 2nd quarter valued at about $10,492,520,000. Norges Bank acquired a new stake in Danaher during the 4th quarter worth $2,177,106,000. Jupiter Topco LLC bought a new stake in shares of Danaher during the 2nd quarter valued at $1,456,317,000. Generation Investment Management LLP acquired a new position in shares of Danaher in the 2nd quarter valued at $1,287,949,000. Finally, Bank of America Corp DE acquired a new position in shares of Danaher in the 2nd quarter valued at $993,846,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Price Performance

DHR stock opened at $216.41 on Friday. The stock has a 50-day moving average price of $199.46 and a two-hundred day moving average price of $192.52. The stock has a market cap of $152.13 billion, a PE ratio of 38.44, a price-to-earnings-growth ratio of 2.69 and a beta of 0.78. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.77 earnings per share. Equities analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts have weighed in on the company. Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Guggenheim reduced their price objective on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Piper Sandler assumed coverage on shares of Danaher in a research note on Thursday, June 11th. They issued a “neutral” rating and a $200.00 target price for the company. DZ Bank started coverage on shares of Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price target for the company. Finally, Royal Bank Of Canada upped their price objective on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Danaher has an average rating of “Moderate Buy” and an average target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.